| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
"Just the facts, ma'am."

While this sentence came to known as the radio and TV crime drama Dragnet's popular catchphrase, it's also a line that journalism teachers and professors and editors across the country use to keep overzealous reporters and writers in line. Those four words sum up the mission of any good news organization: report the facts to the people, and let them form their own opinions.

It's not a hard-and-fast rule. As with any philosophy, there is room for interpretation. Occasionally, and seemingly more often these days in the era of what I call "fast food" journalism—"give it to me now, it doesn't have to be good or even hot, I'm just hungry"—news organizations state the facts, but bend the rule slightly and present or slant the news in an attention-grabbing way that sells papers, increases Web site visits and spikes their Google rankings.

Unfortunately, this tactic—which might make sense from a business standpoint—doesn't always give the reader the whole story. Then the whole thing goes "viral"—meaning it attacks the Web like a bad case of the swine flu—and before you know it, the slanted version of the news becomes the story.

This was the case last month as many major news groups elected to take what should have been perceived as good news in a bad economy, and presented it as yet another slam on greedy, bloodsucking Big Pharma.

Seeking to help unemployed Americans who have recently lost their jobs and health insurance to continue to take their prescriptions, Pfizer Inc. announced a program that enables these folks and their families to receive any Pfizer medicines they take for free for up to one year. According to Pfizer, nearly 46 million Americans lack health insurance coverage, and that number is increasing as unemployment rates reach their highest levels in 25 years.

But to the rabid media, that isn't what's important here. Here's what is: "Pfizer offers free Viagra to unemployed Americans." Yes, Viagra is one of Pfizer's many blockbuster drugs, but what about the millions of unemployed Americans who would benefit from free antibiotics, heart medications and antidepressants?

As a trade journalist, I have sometimes been accused by my "mainstream media" peers of being an "apologist" for the industries I cover. While I think that viewpoint is off-base, and Big Pharma is far from perfect, this is one of those times where I'm going to call a spade a spade and say, "shame on you." Amidst the daily reports of gloom and doom, at a time when many Americans are being forced to choose between keeping their lights on and buying their medications, couldn't we have just reported the facts and let Jay Leno and David Letterman deliver the punchlines? Is it any wonder that most Americans express dissatisfaction with our healthcare system?

In an unrelated but relevant story, Entrepreneur, a publisher based in Irvine, Calif., has filed a motion U.S. District Court in the Eastern District of New York to dismiss a $178 million lawsuit brought against it by a group of investors who allege the magazine misled them about a company featured on its "Hot 100" list. Citing rulings in similar court cases, Entrepreneur actually argued that it is "under no duty to provide information with care to its readers."

Unfortunately, Average Joe Newspaper Reader isn't aware of that. What a shame.

About the Author

Related Topics

Published In

Volume 5 - Issue 6 | June 2009

June 2009

June 2009 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue